In Q1 following a development achievement, CollPlant received a $2 million payment from AbbVie -- Advancement of regenerative breast implant program continues; encouraging findings continue ...

Dave Howson, Global President, departing company to return to UKCathy Clay, EVP and Global Head of Derivatives, and Chris Isaacson, EVP and Chief Operating Officer, expand global leadership ...